Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 13 - Number 9
Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
, 13(9): 915 - 929Yulong Shang, Xiqiang Cai and Daiming Fan
DOI: 10.2174/15680096113136660097
Regulation of Mesenchymal Phenotype by MicroRNAs in Cancer
, 13(9): 930 - 934Jinchun Yan, Kiranmai Gumireddy, Anping Li and Qihong Huang
DOI: 10.2174/15680096113136660098
MicroRNAs as Critical Regulators Involved in Regulating Epithelial- Mesenchymal Transition
, 13(9): 935 - 944Xiaodi Zhao, Yuanyuan Lu, Yongzhan Nie and Daiming Fan
DOI: 10.2174/15680096113136660099
Emerging Role of Mucins in Epithelial to Mesenchymal Transition
, 13(9): 945 - 956Moorthy P. Ponnusamy, Parthasarathy Seshacharyulu, Imayavaramban Lakshmanan, Arokia P. Vaz, Seema Chugh and Surinder K. Batra
DOI: 10.2174/15680096113136660100
Regulation of EMT by Notch Signaling Pathway in Tumor Progression
, 13(9): 957 - 962Yumei Li, Jia Ma, Xiujuan Qian, Qiong Wu, Jun Xia, Lucio Miele, Fazlul H. Sarkar and Zhiwei Wang
DOI: 10.2174/15680096113136660101
The Role of Snail in EMT and Tumorigenesis
, 13(9): 963 - 972Yifan Wang, Jian Shi, Kequn Chai, Xuhua Ying and Binhua P. Zhou
DOI: 10.2174/15680096113136660102
Epigenetic Regulation of Epithelial to Mesenchymal Transition
, 13(9): 973 - 985Peiwei Huangyang and Yongfeng Shang
DOI: 10.2174/15680096113136660103
Regulation of EMT by KLF4 in Gastrointestinal Cancer
, 13(9): 986 - 995Jiujie Cui, Min Shi, Ming Quan and Keping Xie
DOI: 10.2174/15680096113136660104
Decoding the Knots of Initiation of Oncogenic Epithelial-Mesenchymal Transition in Tumor Progression
, 13(9): 996 - 1011Pengda Guo, Aidi Gao, Gaochuan Zhang, Hongyan Han and Quansheng Zhou
DOI: 10.2174/15680096113136660105
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
Center for Drug Discovery
University of Houston
Houston, TX
Biography
Biography of Ruiwen Zhang
Ruiwen Zhang is the Robert L. Boblitt Endowed Professor in Drug Discovery and Director of the Drug Discovery Institute at the University of Houston. With over 30 years of experience in the field of biomedical research, particularly in the area of clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH and DoD, and other agencies. He has published more than 230 papers, 2 books, and more than 50 invited reviews/book chapters as well as more than 180 meeting abstracts. For his outstanding contributions in pharmaceutical sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009. Dr. Zhang is recently elected as Fellow of National Academy of Inventors (2018).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net